Transparency Market Research reported on the expansion of the orthobiological product market.
Here are seven things to know:
1. The worldwide orthobiological products market is anticipated to grow to $15.3 billion by 2022 due to increasing growth in the medical devices industry.
2. Various factors including growing awareness toward the adoption of orthobiological products, development in technology and an increase in the number of orthopedic-related procedures contribute to the expanding orthobiological market.
3. Innovations in technology have provided orthopedics with newer alternatives that offer patients better comfort and durability.
4. Orthobiologics entails the use of biology and biochemistry in developing bone and tissue replacement materials, and is the fastest growing segment of the orthopedic industry.
5. The market is segmented based on applications including:
• Bone grafting
• Fracture repair
• Spinal surgery
• Revision hip and knee replacement
• Cartilage repair and regeneration
• Tendon and ligament repair
6. The orthobiological report analyzed geographic locations such as North America, Asia Pacific, Europe and other nations across the world.
7. Several companies are key players in the growing market. Such companies include:
• Allograft Tissue Systems
• Baxter International
• Berkeley Advanced Biomaterials
• Bone Biologics
• Bone Solutions
• Interventional Spine
For more articles:
Canaccord Genuity reiterates Stryker 'buy' rating — 5 notes
Dr. Raymond Wurapa collaborates with Medline on new limb basin: 5 takeaways
22 things to know about Stryker